Post by ehsanulh125 on Jan 9, 2024 7:07:10 GMT 1
In June 2018, the European Food Safety Agency (EFSA) and the European Chemicals Administration (ECHA) released the supporting guidance documents for the identification standards of endocrine disruptors applicable to the registration and evaluation of pesticides and disinfectants in the European Union. It is stipulated that as of November 10, 2018, the products under application or newly applied for EU Pesticides will submit the endocrine interference assessment data, and the authorized products will also receive the assessment of endocrine disruptors in succession.
In addition, according Country Email List to the EU Pesticide Regulation (EC) No 1107/2009, substances with endocrine disrupting properties that may be harmful to humans or non-target organisms cannot be approved (* if the applicant can demonstrate that the exposure of the active substance to humans and non-target Organisms can be ignored, it can be approved, but it will be judged as CfS substance). Since then, the evaluation of endocrine disruptors has become one of the main difficulties in the evaluation of pesticides in the European Union. Due to its high test costs, long evaluation cycle, great difficulty and great impact of the evaluation results on the approval of Active substances in the European Union, it has attracted wide attention from stakeholders.
Evaluation results of endocrine disturbance characteristics In order to better implement the EU Transparency regulation, from June 2022, EFSA announced that the evaluation results of the endocrine disrupting properties of pesticide active substances will be published on the official website of EFSA, and will be updated regularly after the release of the report of the high-level meeting after Each round of pesticide peer review expert meeting. Currently, the last update date of this document is September 13, 2022. The document contains the progress in evaluation of endocrine disrupting properties of 95 pesticide active substances. The active substances that may be considered as human or (and) non-target biological endocrine disruptors after preliminary.
In addition, according Country Email List to the EU Pesticide Regulation (EC) No 1107/2009, substances with endocrine disrupting properties that may be harmful to humans or non-target organisms cannot be approved (* if the applicant can demonstrate that the exposure of the active substance to humans and non-target Organisms can be ignored, it can be approved, but it will be judged as CfS substance). Since then, the evaluation of endocrine disruptors has become one of the main difficulties in the evaluation of pesticides in the European Union. Due to its high test costs, long evaluation cycle, great difficulty and great impact of the evaluation results on the approval of Active substances in the European Union, it has attracted wide attention from stakeholders.
Evaluation results of endocrine disturbance characteristics In order to better implement the EU Transparency regulation, from June 2022, EFSA announced that the evaluation results of the endocrine disrupting properties of pesticide active substances will be published on the official website of EFSA, and will be updated regularly after the release of the report of the high-level meeting after Each round of pesticide peer review expert meeting. Currently, the last update date of this document is September 13, 2022. The document contains the progress in evaluation of endocrine disrupting properties of 95 pesticide active substances. The active substances that may be considered as human or (and) non-target biological endocrine disruptors after preliminary.